Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study. (Record no. 28596986)

MARC details
000 -LEADER
fixed length control field 01696 a2200481 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517224832.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201810s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1998-4138
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.4103/jcrt.JCRT_738_17
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Li, Yong
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20181024
245 00 - TITLE STATEMENT
Title Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of cancer research and therapeutics
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 772-779 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Capecitabine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Colorectal Neoplasms
General subdivision pathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liver Neoplasms
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Staging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organoplatinum Compounds
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxaliplatin
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, Guo-Xin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chu, Zhong-Hua
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hao, Chun-Yi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jiang, Zhi-Wei
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chen, Huan-Qiu
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lin, Jian-Jiang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, De-Chuan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hu, Bing
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wang, Xi-Shan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lin, Feng
773 0# - HOST ITEM ENTRY
Title Journal of cancer research and therapeutics
Related parts vol. 14
-- no. 4
-- p. 772-779
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.4103/jcrt.JCRT_738_17">https://doi.org/10.4103/jcrt.JCRT_738_17</a>
Public note Available from publisher's website

No items available.